Advocacy Feature image
ePolicy 300x175
eAdvocacy Center 300x175
  • news-thumbnail

    ePolicy News August, 2011

    August 01, 2011
    Federal Appeals Court Upholds Patenting of Genes in Myriad Lawsuit
    In a split decision, the U.S. Federal Circuit Court of Appeals ruled late last month to partially reverse a lower court ruling challenging patents on two human genes associated with hereditary breast cancer and ovarian cancer. The ruling upholds the right of Myriad Genetics, to patent two “isolated” human genes, BRCA1 and BRCA2, thus granting the company the exclusive right to perform diagnostic tests on the genes and preventing other researchers from even looking at the genes without first getting permission from Myriad.
    Get the latest news from ASCP's offices in Washington DC. Read more
  • news-thumbnail

    Together, we have a strong voice in Washington

    July 20, 2011
    At ASCP, we know we’re stronger together. That’s why our diverse membership of more than 100,000 pathologists, medical affiliates, lab professionals, clinical scientists, and students work together to influence policymakers and create lasting change at the local, state and national levels. With our unified voice and focus on patients, ASCP has a seat at the table when addressing major issues that concern the pathology community including competitive bidding, anti-markup provisions, workforce shortages, and direct billing.
    Read more
  • news-thumbnail
  • news-thumbnail

    Action Alert archive

    June 21, 2011
    ASCP Action Alerts are sent out to ASCP's membership to provide up-to-date legislative and regulatory information on the most current pathology and laboratory medicine issues in state and federal government. These alerts allow ASCP members and colleagues to become educated about the issues at hand and take action by contacting their local or federal officials with a few clicks of a mouse. Read more